December 29, 2025
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreNovember 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreJanuary 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreDecember 29, 2025
According to market estimations, the AR and VR in the healthcare market size is calculated at $3.05 bn in 2025 is to hit $27.98 bn by 2035. AR and VR are transforming healthcare with applications in surgical simulations, patient education, and mental health therapy. They're enhancing medical training, improving diagnostics, and enabling immersive t...
December 29, 2025
Projections indicate the U.S. child care market will increase from USD 65.13 billion in 2025 to USD 99.23 billion by 2035, experiencing a CAGR of 4.3% over the next 10 years. U.S. child care includes daycare centers, in-home providers, and preschool programs that support working families by caring for young children. Costs vary widely, and quality ...
December 29, 2025
Projections indicate that, the global cell culture microcarriers market will increase from USD 3.18 billion in 2024 to USD 7.2 billion by 2034, experiencing a CAGR of 8.54% over the next 10 years.The growing research activities and advancements in cell culture technologies bolster market growth. North America dominated due to the growing demand for...
December 29, 2025
Based on market forecasts, the global fondaparinux market, projected at USD 721 million in 2025, is expected to reach USD 1419.61 million by 2035, growing at a CAGR of 6.36% over the forecast period. The increasing number of surgeries and growing research activities drive the global market. North America dominated the global market owing to the pre...
December 29, 2025
Market insights predict the global sciatica treatment industry will increase from USD 796 million in 2025 to USD 1171.76 million by 2035, achieving a CAGR of 3.94%. The market is driven by sedentary lifestyles and aging populations, fuel demand for effective pain management solutions. North America is leading the global market, driven by robust hea...
December 29, 2025
Projections indicate that, the global ankylosing spondylitis market will increase from USD 6.7 billion in 2025 to USD 11.83 billion by 2035, experiencing a CAGR of 5.85% over the next 10 years. The rising prevalence of autoimmune disorders and growing research and development activities drive the global market. A robust healthcare infrastructure an...
December 29, 2025
According to market projections, the cardiometabolic diseases market was valued at USD 292.04 billion in 2026 and is projected to reach approximately USD 1,987.69 billion by 2035, growing at a strong CAGR of 23.75% from 2026 to 2035. The cardiometabolic diseases market analysis covers detailed segment data by disease type, therapeutic class, treatm...
December 29, 2025
Market insights predict the global blood-brain barrier industry will increase from USD 6.03 billion in 2025 to USD 55.45 billion by 2035, achieving a CAGR of 24.85%.The rising prevalence of neurological disorders and advances in neuroscience technology drive the global market. The availability of state-of-the-art research and development facilities...
December 29, 2025
The GLP-1 small molecule market covers comprehensive insights on global market size, segmentation, regional performance, and competitive dynamics across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The market accounted for nearly 40% revenue share in North America in 2025, while Asia Pacific is projected to ...
December 29, 2025
The therapeutic neurotoxin market was valued at USD 6.39 billion in 2025 and is projected to reach USD 6.94 billion in 2026, expanding to approximately USD 14.5 billion by 2035 at a CAGR of 8.54% 2026 to 2035. The report covers detailed segment analysis by neurotoxin type, end users, and route of administration....
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com